ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,976.70
      -0.15%
      US Tech 100
      20,438.80
      -0.25%
      Dow Jones
      43,929.02
      -0.07%
      Brent Oil
      72.535
      0.93%
      Bitcoin
      87,802.71
      -3.05%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Aquestive Therapeutics Inc (AQST) Quote

      Aquestive Therapeutics Inc

      Aquestive Therapeutics Inc (AQST)

      NASDAQ
      4.75
      -0.08
      ( -1.66% )
      Updated: 10:57:15
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      4.75
      Bid
      4.74
      Ask
      4.75
      Volume
      817,309
      4.62 Day's Range 4.86
      1.55 52 Week Range 6.23
      Market Cap
      433.096M
      Previous Close
      4.83
      Open
      4.83
      Last Trade
      126
      @
      4.7477
      Last Trade Time
      10:57:15
      Financial Volume
      $ 3,880,900
      VWAP
      4.7484
      Average Volume (3m)
      1,284,047
      Shares Outstanding
      91,178,193
      Dividend Yield
      -
      PE Ratio
      -55.16
      Earnings Per Share (EPS)
      -0.09
      Revenue
      50.58M
      Net Profit
      -7.87M

      About Aquestive Therapeutics Inc

      Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the t... Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.aquestive.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Aquestive Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AQST. The last closing price for Aquestive Therapeutics was $4.83. Over the last year, Aquestive Therapeutics shares have traded in a share price range of $ 1.55 to $ 6.23.

      Aquestive Therapeutics currently has 91,178,193 shares outstanding. The market capitalization of Aquestive Therapeutics is $440.39 million. Aquestive Therapeutics has a price to earnings ratio (PE ratio) of -55.16.

      Ask ADVFN Intelligence (AI)

      AQST Latest News

      More News

      Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

      WAQRREN, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful...

      November 12 2024
      GlobeNewswire Inc.

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors

      November 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 06 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 04 2024
      Edgar (US Regulatory)

      Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

      Anaphylm™ (epinephrine) Sublingual Film pre-NDA meeting scheduled for fourth quarter 2024AQST-108 (epinephrine) Topical Gel pre-IND meeting scheduled for fourth quarter 2024Libervant® (diazepam...

      November 04 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      October 25 2024
      Edgar (US Regulatory)

      Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College

      Initial placement or subsequent movement of Anaphylm showed no impact on epinephrine pharmacokinetics (PK) or pharmacodynamics (PD), with all results comparable to epinephrine injectionData...

      October 25 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      October 24 2024
      Edgar (US Regulatory)

      Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film

      Completed OAS challenge study meets both primary and secondary endpointsDemonstrates rapid resolution of allergen-related symptoms beginning two minutes after administration Pharmacokinetic (PK...

      October 24 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.24-4.809619238484.995.55924.6216239415.10975744CS
      4-0.15-3.06122448984.95.84.6216304185.21632546CS
      120.061.279317697234.695.84.112840474.95857776CS
      261.546.15384615383.255.82.2413789263.88248329CS
      523.03176.1627906981.726.231.5515763223.86564481CS
      156-1.59-25.07886435336.346.40.6188617873.10745145CS
      260-1.15-19.49152542375.9100.6188440563.99653928CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      PULMPulmatrix Inc
      $ 6.04
      (69.66%)
      		9.63M
      OMEROmeros Corporation
      $ 6.99
      (66.83%)
      		8.06M
      MTEMMolecular Templates Inc
      $ 0.47465
      (47.36%)
      		2.96M
      QUBTQuantum Computing Inc
      $ 3.90
      (46.62%)
      		123.96M
      GORVLazydays Holdings Inc
      $ 1.24
      (34.78%)
      		184.68k
      SOWGSow Good Inc
      $ 4.25
      (-56.68%)
      		1.18M
      NVCTNuvectis Pharma Inc
      $ 6.10
      (-42.83%)
      		1.02M
      TRNRInteractive Strength Inc
      $ 3.77
      (-35.33%)
      		1.05M
      MFHMercurity Fintech Holding Inc
      $ 3.745
      (-31.28%)
      		206.41k
      JTAIJet AI Inc
      $ 5.625
      (-30.73%)
      		226.97k
      ELABElevai Labs Inc
      $ 0.0275
      (11.34%)
      		1.37B
      XTIAXTI Aerospace Inc
      $ 0.0765
      (33.74%)
      		276.31M
      SVMHSRIVARU Holding Ltd
      $ 0.02988
      (23.47%)
      		194.87M
      QUBTQuantum Computing Inc
      $ 3.90
      (46.62%)
      		123.96M
      MVSTMicrovast Holdings Inc
      $ 0.8656
      (8.87%)
      		123.5M

      AQST Discussion

      View Posts
      52172 52172 2 weeks ago
      Smart man 
      👍️0
      52172 52172 2 months ago
      Exactly
      👍️0
      52172 52172 2 months ago
      No brainer!
      👍️0
      Sierra20 Sierra20 2 months ago
      May breakout soon. Adding and building large position. I like their drugs.
      👍️0
      TechandBio TechandBio 2 months ago
      Building a position here.

      $AQST
      👍️0
      Sierra20 Sierra20 3 months ago
      Seeing how fast Neffy maker moved AQST will make the same move.
      👍️0
      Sierra20 Sierra20 3 months ago
      NEFFY is approved. Bad news for AQST very behind
      👍️0
      Sierra20 Sierra20 3 months ago
      Selloff coming
      👍️0
      52172 52172 4 months ago
      Not true
      👍️0
      Sierra20 Sierra20 4 months ago
      Nothing. No updates on Libervant after approval. Now Anaphylm won’t be available for 2 more years.
      👍️0
      52172 52172 4 months ago
      Keep dropping were not done buying!
      👍️0
      52172 52172 4 months ago
      Huge buy opp!
      👍️0
      Sierra20 Sierra20 5 months ago
      It’s heading back to $2. Stop the bleeding please! drug approved but not ready to sell wtf is that? Next earnings will be brutal.
      👍️0
      PonkenPlonken PonkenPlonken 7 months ago
      added. Great science and beautiful chart.
      Offerings became bullish.. dont you know?
      👍️0
      52172 52172 7 months ago
      Is a bargain
      👍️0
      Monksdream Monksdream 7 months ago
      AQST under $5

      👍️0
      52172 52172 7 months ago
      Big turn around imminent
      👍️0
      52172 52172 7 months ago
      Yessir absolutely
      👍️0
      Monksdream Monksdream 8 months ago
      In other words you’re confident about this one from the clinical stage drug discovery sector
      👍️0
      52172 52172 8 months ago
      Not for long
      👍️0
      Monksdream Monksdream 8 months ago
      AQST under $5
      👍️0
      glenn1919 glenn1919 8 months ago
      AQST................................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 8 months ago
      AQST new 52 week hi
      👍️0
      glenn1919 glenn1919 8 months ago
      AQST...........................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      I HATE YOU NOW..LOL
      👍️0
      Monksdream Monksdream 8 months ago
      AQST new 52 week high
      👍️0
      glenn1919 glenn1919 8 months ago
      AQST.....................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783
      👍️0
      52172 52172 8 months ago
      Headed much higher!
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      AQST..EXIT...MASSIVE PLAY
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      AQST...BREAKING 4 BUCKS...BEAST
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      AQST...MONSTER
      👍️0
      TrendTrade2016 TrendTrade2016 9 months ago
      AQST...MONSTER
      👍️0
      TrendTrade2016 TrendTrade2016 9 months ago
      AQST monster bio by the master trend
      👍️0
      glenn1919 glenn1919 9 months ago
      AQST.......................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 9 months ago
      AQST new 52 week high
      👍️0
      TrendTrade2016 TrendTrade2016 9 months ago
      AQST...NEXT BIO WEEKLY BEAST
      👍️0
      52172 52172 9 months ago
      Just the beginning
      👍️0
      Monksdream Monksdream 9 months ago
      AQST new 52 week high
      👍️0
      Sierra20 Sierra20 10 months ago
      Offering coming probably soon.
      👍️0
      Monksdream Monksdream 10 months ago
      AQST new 52 week high
      👍️0
      shankapotamus shankapotamus 2 years ago
      Initiating this one. Fantastic turnaround by company leadership. Look at the ER from last night and see for yourself.
      👍️0
      trendzone trendzone 2 years ago
      Toxic slobs is more like it.
      👍️0
      crudeoil24 crudeoil24 2 years ago
      On going S-3 shelf placement!

      AQST
      👍️0
      crudeoil24 crudeoil24 2 years ago
      Aquestive Therapeutics Announces EPIPHAST II Trial Data For AQST-109; Says 'AQST-109 median time to maximum concentration (Tmax) of 12 minutes was faster than EpiPen Tmax of 22.5 minutes'
      7:05 am ET September 27, 2022 (Benzinga) Print
      AQST-109 median time to maximum concentration (Tmax) of 12 minutes was faster than EpiPen® Tmax of 22.5 minutes
      AQST-109 repeat dosing provided significantly higher drug plasma concentrations with a Tmax of 8 minutes after administration
      Changes in systolic blood pressure and heart rate were similar after a single dose of AQST-109 when compared to a single dose of EpiPen
      End-of-Phase 2 meeting with FDA scheduled for fourth quarter 2022 and remaining clinical studies will commence thereafter
      Company hosts conference call at 8:00 am ET on September 27, 2022
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      https://www.stockscores.com/chart.asp?TickerSymbol=aqst%20&TimeRange=1825&Interval=m&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=200&Indicator1=AccDist&Indicator2=CMF&Indicator3=StochRSI&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      me=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=200&Indicator1=AccDist&Indicator2=CMF&Indicator3=StochRSI&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      nice
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      like this
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      strange POS
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      strange POS
      👍️0

      Your Recent History

      NASDAQ
      AQST
      Aquestive Therapeutics
      Delayed Upgrade Clock